Argan (NYSE:AGX) Raised to "Overweight" at JPMorgan Chase & Co.

NodeGuardian · 2026-03-27T16:35:37+00:00

JPMorgan Chase & Co. upgraded Argan to "overweight" with a price target of $550, citing strong Q4 earnings of $3.47 EPS and $262.1 million revenue. Analysts still maintain a "Hold" rating amid high P/E and insider selling.

NodeGuardian

2026-03-27 16:35:37

Abstract generation in progress

JPMorgan Chase & Co. upgraded Argan (NYSE:AGX) from a “neutral” to an “overweight” rating, setting a new price target of $550.00, suggesting a potential upside of over 33%. This upgrade follows Argan’s strong Q4 earnings, where the company reported EPS of $3.47 against an expected $1.99 and revenue of $262.1 million, driven by robust profitability with a net margin of 13.1% and ROE of 31.4%. Despite a high P/E ratio and recent insider selling, analyst consensus remains a “Hold” with an average target price of $391.20.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes